These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28617075)

  • 1. Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews.
    Weisner TS; Murray DW; Jensen PS; Mitchell JT; Swanson JM; Hinshaw SP; Wells K; Hechtman L; Molina BSG; Arnold LE; Sorensen P; Stehli A
    J Atten Disord; 2018 Jul; 22(9_suppl):10S-20S. PubMed ID: 28617075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.
    Mitchell JT; Weisner TS; Jensen PS; Murray DW; Molina BSG; Arnold LE; Hechtman L; Swanson JM; Hinshaw SP; Victor EC; Kollins SH; Wells KC; Belendiuk KA; Blonde A; Nguyen C; Ambriz L; Nguyen JL
    J Atten Disord; 2018 Jul; 22(9_suppl):49S-60S. PubMed ID: 28166690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use.
    Swanson JM; Wigal T; Jensen PS; Mitchell JT; Weisner TS; Murray D; Arnold LE; Hechtman L; Molina BSG; Owens EB; Hinshaw SP; Belendiuk K; Howard A; Wigal SB; Sorensen P; Stehli A
    J Atten Disord; 2018 Jul; 22(9_suppl):21S-37S. PubMed ID: 29090967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study.
    Molina BSG; Howard AL; Swanson JM; Stehli A; Mitchell JT; Kennedy TM; Epstein JN; Arnold LE; Hechtman L; Vitiello B; Hoza B
    J Child Psychol Psychiatry; 2018 Jun; 59(6):692-702. PubMed ID: 29315559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results.
    Hechtman L; Swanson JM; Sibley MH; Stehli A; Owens EB; Mitchell JT; Arnold LE; Molina BS; Hinshaw SP; Jensen PS; Abikoff HB; Perez Algorta G; Howard AL; Hoza B; Etcovitch J; Houssais S; Lakes KD; Nichols JQ;
    J Am Acad Child Adolesc Psychiatry; 2016 Nov; 55(11):945-952.e2. PubMed ID: 27806862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA).
    Fernández de la Cruz L; Simonoff E; McGough JJ; Halperin JM; Arnold LE; Stringaris A
    J Am Acad Child Adolesc Psychiatry; 2015 Jan; 54(1):62-70.e3. PubMed ID: 25524791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.
    Swanson JM; Arnold LE; Molina BSG; Sibley MH; Hechtman LT; Hinshaw SP; Abikoff HB; Stehli A; Owens EB; Mitchell JT; Nichols Q; Howard A; Greenhill LL; Hoza B; Newcorn JH; Jensen PS; Vitiello B; Wigal T; Epstein JN; Tamm L; Lakes KD; Waxmonsky J; Lerner M; Etcovitch J; Murray DW; Muenke M; Acosta MT; Arcos-Burgos M; Pelham WE; Kraemer HC;
    J Child Psychol Psychiatry; 2017 Jun; 58(6):663-678. PubMed ID: 28295312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).
    March JS; Swanson JM; Arnold LE; Hoza B; Conners CK; Hinshaw SP; Hechtman L; Kraemer HC; Greenhill LL; Abikoff HB; Elliott LG; Jensen PS; Newcorn JH; Vitiello B; Severe J; Wells KC; Pelham WE
    J Abnorm Child Psychol; 2000 Dec; 28(6):527-41. PubMed ID: 11104315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
    Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
    JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up of the MTA-study in children with ADHD: what do the data tell us, and what not?].
    Buitelaar JK
    Tijdschr Psychiatr; 2010; 52(4):255-7. PubMed ID: 20503166
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction: Just Say No? New Insights About Change Versus Constancy in Substance Use Behavioral Decisions in Youth With and Without ADHD.
    Jensen PS; Weisner T; Hinshaw SP
    J Atten Disord; 2018 Jul; 22(9_suppl):3S-9S. PubMed ID: 29633895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of ADHD pharmacotherapy in children.
    Gilchrist RH; Arnold EL
    Pediatr Ann; 2008 Jan; 37(1):46-51. PubMed ID: 18240853
    [No Abstract]   [Full Text] [Related]  

  • 18. Bulimia nervosa symptoms in the multimodal treatment study of children with ADHD.
    Mikami AY; Hinshaw SP; Arnold LE; Hoza B; Hechtman L; Newcorn JH; Abikoff HB
    Int J Eat Disord; 2010 Apr; 43(3):248-59. PubMed ID: 19378318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?].
    Hansen L; Thomsen PH
    Ugeskr Laeger; 2005 Nov; 167(48):4555-9. PubMed ID: 16324436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.
    Biederman J; Wilens T; Mick E; Spencer T; Faraone SV
    Pediatrics; 1999 Aug; 104(2):e20. PubMed ID: 10429138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.